Feed SYK
SY

Stryker

SYK · NYSE

$275.57 +2.06% (+$5.56)
1M -18.76%
Market Cap $103.5B
P/E Ratio 27.76x
Div. Yield 1.29%
ROE 16.36%

Bulios Fair Price

$157.26

42.9% downside

Current Price

$275.57

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SYK is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
8/9
Valuation
42 /100
Fair
P/E 27.76x
EV/EBITDA 18.40x
PEG 3.77x
Growth
77 /100
Growing
EPS growth 10.83%
Rev. growth 10.83%
Book val. growth 10.50%
Profitability
94 /100
Strong
Gross margin 65.17%
Net margin 14.43%
FCF margin 18.20%
Quality
62 /100
Average
ROIC 9.82%
ROE 16.36%
Asset turnover 0.54x
Debt
75 /100
Low
Debt/Equity 0.62x
Current ratio 2.16x
Net debt/EBITDA 1.85x
Stability
96 /100
Stable
Beta 0.77x
Rev. volatility 0.52%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SYK
Online

About the company

Stryker Corporation (SYK) is an American company specializing in the manufacture and distribution of medical devices and technologies for the healthcare industry. The company offers a wide range of products, including orthopedic implants, surgical instruments, medical devices for imaging and patient monitoring, and other equipment used in healthcare facilities. Stryker Corporation is known for its innovative technology and contributes to the development of advanced treatment procedures and the improvement of patient care. The company collaborates with medical professionals and healthcare institutions worldwide. Stryker Corporation adheres to high standards of quality and safety for its products and emphasizes the improvement of health and quality of life for patients. Its innovative medical technologies are sought after and utilized in hospitals and healthcare facilities around the world. Shares of Stryker Corporation (SYK) could represent an intriguing investment opportunity for those who believe in the growth and significance of the healthcare industry and the benefits of innovative medical technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Kevin A. Lobo

Employees

56,000

Headquarters

Portage

Upcoming events

30 SEP

Ex-Dividend

Ex-dividend date

17d
29 OCT

Earnings

Upcoming earnings report

46d
30 OCT

Dividend Payment

Payment date

47d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.